Index - P/E - EPS (ttm) - Insider Own 49.88% Shs Outstand 31.91M Perf Week -
Market Cap 879.12M Forward P/E - EPS next Y - Insider Trans - Shs Float 16.00M Perf Month -
Enterprise Value 939.30M PEG - EPS next Q - Inst Own 13.57% Short Float - Perf Quarter -
Income - P/S - EPS this Y - Inst Trans - Short Ratio - Perf Half Y -
Sales - P/B - EPS next Y - ROA - Short Interest - Perf YTD 4.36%
Book/sh -1.90 P/C 54.03 EPS next 5Y - ROE - 52W High 32.44 -15.07% Perf Year -
Cash/sh 0.51 P/FCF - EPS past 3/5Y - - ROIC - 52W Low 20.16 36.66% Perf 3Y -
Dividend Est. - EV/EBITDA - Sales past 3/5Y - - Gross Margin - Volatility - - Perf 5Y -
Dividend TTM - EV/Sales - EPS Y/Y TTM - Oper. Margin - ATR (14) 5.20 Perf 10Y -
Dividend Ex-Date - Quick Ratio 2.23 Sales Y/Y TTM - Profit Margin - RSI (14) - Recom -
Dividend Gr. 3/5Y - - Current Ratio 2.23 EPS Q/Q - SMA20 2.07% Beta - Target Price -
Payout - Debt/Eq 0.32 Sales Q/Q - SMA50 2.07% Rel Volume 0.09 Prev Close 27.83
Employees - LT Debt/Eq 0.29 Earnings - SMA200 2.07% Avg Volume 500.99K Price 27.55
IPO Feb 06, 2026 Option/Short No / Yes EPS/Sales Surpr. - - Trades
Volume 44,428 Change -1.01%
SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. Its lead product candidate, Bimatoprost Drug Pad-IOL System (BIM-IOL System), is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) for patients who have wither open-angel glaucoma (OAG) or ocular hypertension (OHT). The company was founded in January 2019 by Malik Y. Kahook and Glenn Sussman and is headquartered in Aliso Viejo, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
RA CAPITAL MANAGEMENT, L.P. Director Feb 09 '26 Buy 16.00 3,690,000 59,040,000 5,966,439 Feb 11 05:15 PM Behbahani Ali Director Feb 09 '26 Buy 16.00 937,500 15,000,000 6,035,038 Feb 11 04:30 PM Florence Anthony A. Jr. 10% Owner Feb 09 '26 Buy 16.00 937,500 15,000,000 6,035,038 Feb 11 04:30 PM BASKETT FOREST 10% Owner Feb 09 '26 Buy 16.00 937,500 15,000,000 6,035,038 Feb 11 04:30 PM New Enterprise Associates 17, 10% Owner Feb 09 '26 Buy 16.00 937,500 15,000,000 6,035,038 Feb 11 04:30 PM Yang Rick 10% Owner Feb 09 '26 Buy 16.00 937,500 15,000,000 6,035,038 Feb 11 04:30 PM Makhzoumi Mohamad 10% Owner Feb 09 '26 Buy 16.00 937,500 15,000,000 6,035,038 Feb 11 04:30 PM SANDELL SCOTT D 10% Owner Feb 09 '26 Buy 16.00 937,500 15,000,000 6,035,038 Feb 11 04:30 PM Chang Carmen 10% Owner Feb 09 '26 Buy 16.00 937,500 15,000,000 6,035,038 Feb 11 04:30 PM Walker Paul Edward 10% Owner Feb 09 '26 Buy 16.00 937,500 15,000,000 6,035,038 Feb 11 04:30 PM Mathers Edward T 10% Owner Feb 09 '26 Buy 16.00 937,500 15,000,000 6,035,038 Feb 11 04:30 PM Pardo Geoffrey B Director Feb 09 '26 Buy 16.00 312,500 5,000,000 2,187,513 Feb 11 04:09 PM Khan Bilal Arshad Director Feb 09 '26 Buy 16.00 115,000 1,840,000 251,427 Feb 11 04:07 PM Khan Bilal Arshad Director Feb 09 '26 Buy 16.00 20,000 320,000 25,450 Feb 11 04:07 PM Nielsen Kirk G. Director Feb 09 '26 Buy 16.00 165,000 2,640,000 3,310,619 Feb 10 06:09 PM Vensana Capital I GP, LLC 10% Owner Feb 09 '26 Buy 16.00 165,000 2,640,000 3,310,619 Feb 10 06:08 PM
